Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Genitourinary 3Head & Neck 1

Conditions

Breast Neoplasms 4Muscle Weakness 2Motor Activity 2Muscular Atrophy 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Creatine × Breast × Clear all
NCT07372144 2026-01-28

IARA

D'Or Institute for Research and Education

Phase 3 Not yet recruiting
227 enrolled
Breast

Breast Neoplasms

NCT06395506 2025-12-24

THRIVE

The University of Texas Medical Branch, Galveston

Phase NA Recruiting
60 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscle Weakness

NCT05878106 2024-05-09

CaRTiC

University of Deusto

Phase NA Unknown
120 enrolled
Breast

Breast Neoplasms

NCT04207359 2023-07-25

Effects of Creatine Supplementation in Breast Cancer Survivors

The University of Texas Health Science Center at San Antonio

Phase NA Completed
20 enrolled
Breast

Breast Neoplasms, Motor Activity, Muscular Atrophy, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡